Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%)
< Home < Back

Natco Pharma - Quaterly Results

Date: 12-08-2025
The revenue slipped marginally during the June 2025 quarter. A decline of about Rs. 11927.00 millions was observed as compared to Rs. 12369.00 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 4641.00  millions from Rs. 6363.00 millions ,decline by -27.06%.The Operating Profit of the company witnessed a decrease to 5993.00 millions from 8028.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 11927.00 12369.00 -3.57 11927.00 12369.00 -3.57 40945.00 35689.00 14.73
Other Income 596.00 398.00 49.75 596.00 398.00 49.75 3213.00 1047.00 206.88
PBIDT 5993.00 8028.00 -25.35 5993.00 8028.00 -25.35 24656.00 17417.00 41.56
Interest 26.00 44.00 -40.91 26.00 44.00 -40.91 196.00 145.00 35.17
PBDT 5967.00 7984.00 -25.26 5967.00 7984.00 -25.26 24460.00 17272.00 41.62
Depreciation 538.00 404.00 33.17 538.00 404.00 33.17 2200.00 1719.00 27.98
PBT 5429.00 7580.00 -28.38 5429.00 7580.00 -28.38 22260.00 15553.00 43.12
TAX 788.00 1217.00 -35.25 788.00 1217.00 -35.25 3756.00 2487.00 51.03
Deferred Tax -272.00 -107.00 154.21 -272.00 -107.00 154.21 -319.00 -361.00 -11.63
PAT 4641.00 6363.00 -27.06 4641.00 6363.00 -27.06 18504.00 13066.00 41.62
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 358.00 0.00
PBIDTM(%) 50.25 64.90 -22.58 50.25 64.90 -22.58 60.22 48.80 23.39